1. Home
  2. LDWY vs CYCN Comparison

LDWY vs CYCN Comparison

Compare LDWY & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LDWY
  • CYCN
  • Stock Information
  • Founded
  • LDWY 1990
  • CYCN N/A
  • Country
  • LDWY United States
  • CYCN United States
  • Employees
  • LDWY N/A
  • CYCN N/A
  • Industry
  • LDWY Advertising
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LDWY Consumer Discretionary
  • CYCN Health Care
  • Exchange
  • LDWY Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • LDWY 9.2M
  • CYCN 7.8M
  • IPO Year
  • LDWY 1991
  • CYCN N/A
  • Fundamental
  • Price
  • LDWY $4.43
  • CYCN $3.27
  • Analyst Decision
  • LDWY
  • CYCN
  • Analyst Count
  • LDWY 0
  • CYCN 0
  • Target Price
  • LDWY N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • LDWY 1.3K
  • CYCN 8.6K
  • Earning Date
  • LDWY 08-08-2024
  • CYCN 07-26-2024
  • Dividend Yield
  • LDWY N/A
  • CYCN N/A
  • EPS Growth
  • LDWY N/A
  • CYCN N/A
  • EPS
  • LDWY N/A
  • CYCN N/A
  • Revenue
  • LDWY $14,244,000.00
  • CYCN N/A
  • Revenue This Year
  • LDWY N/A
  • CYCN N/A
  • Revenue Next Year
  • LDWY N/A
  • CYCN N/A
  • P/E Ratio
  • LDWY N/A
  • CYCN N/A
  • Revenue Growth
  • LDWY 337.74
  • CYCN N/A
  • 52 Week Low
  • LDWY $3.72
  • CYCN $1.75
  • 52 Week High
  • LDWY $8.00
  • CYCN $5.25
  • Technical
  • Relative Strength Index (RSI)
  • LDWY 42.44
  • CYCN 56.76
  • Support Level
  • LDWY $4.43
  • CYCN $3.10
  • Resistance Level
  • LDWY $4.51
  • CYCN $3.66
  • Average True Range (ATR)
  • LDWY 0.05
  • CYCN 0.55
  • MACD
  • LDWY 0.03
  • CYCN 0.05
  • Stochastic Oscillator
  • LDWY 0.03
  • CYCN 64.29

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: